Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Yarrow Bioscience, Inc. Completes Merger with Yarrow Bioscience Operating Company Corp.

PUBLIC · YARWSep 10, 2026about 4 hours ago

Acquiring Company

Yarrow Bioscience

Acquired Company

Yarrow Bioscience Operating Company

United StatesNew HavenBiotechnologyHealth CareTherapeuticsBiotechnologyHealth Care

Description

On September 10, 2026, Yarrow Bioscience, Inc. announced the completion of its merger with Yarrow Bioscience Operating Company Corp. This merger is a pivotal step in their strategic growth, allowing them to streamline operations and enhance their market presence in the biosciences sector. Following the merger, the company is expected to focus on advancing its innovative product development.

Company Information

Company

Yarrow Bioscience

Location

United States

About

Yarrow Bioscience, Inc. is a biotechnology company focused on developing novel therapies for autoimmune diseases. Founded by RTW Investments, Yarrow is advancing its lead program, YB-101, which targets thyroid-stimulating hormone receptors for the treatment of Graves' disease and thyroid eye disease. The company aims to address significant unmet needs in these therapeutic areas.

Don't miss Yarrow Bioscience's next move

Get an email the moment Yarrow Bioscience makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Igor
Senior decision-maker at this company
••••••••@••••••••

See Igor's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Yarrow Bioscience's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Yarrow Bioscience Operating Company?

Yarrow Bioscience Operating Company was acquired by Yarrow Bioscience, based in United States. The deal was reported on September 10, 2026. Yarrow Bioscience, Inc. is a biotechnology company focused on developing novel therapies for autoimmune diseases. Yarrow Bioscience is publicly traded (YARW) and operates in Biotechnology.

When did Yarrow Bioscience acquire Yarrow Bioscience Operating Company?

Yarrow Bioscience's acquisition of Yarrow Bioscience Operating Company was reported on September 10, 2026. On September 10, 2026, Yarrow Bioscience, Inc. announced the completion of its merger with Yarrow Bioscience Operating Company Corp. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Yarrow Bioscience Operating Company do?

Previously known as Yarrow Bioscience, Inc., Yarrow Bioscience Operating Company Corp. is involved in the biosciences sector, aiming to enhance health and wellness through biotechnological innovations. It is privately held, operating in Biotechnology, and is based in New Haven.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.